Statistical analysis of pathologic risk factors for intramyometrial lymphvascular space involvement in myoinvasive endometrial carcinoma

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 1330-1335

  Honore, L H ^a   Hanson, J ^a  

^a CROSS CANCER INSTITUTE   (Canada)

Author keywords

Endometrial carcinoma; Lymphvascular space involvement; Relative risk; Surgicopathologic variables; Univariate and multivariate analysis

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INFILTRATION; CANCER INVASION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; LYMPH VESSEL; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SALPINGOOOPHORECTOMY; STATISTICAL ANALYSIS; UNIVARIATE ANALYSIS; UTERINE CERVIX;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOMETRIUM; NEOPLASM INVASIVENESS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33745069562     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00538.x     Document Type: Article

References (36)

1. Liotta LA Kohn E. Cancer invasion and metastases. JAMA 1990 263: 1112 26.
2. Sivridis E Buckley CH Fox H. The prognostic significance of lymphatic vascular space invasion in endometrial carcinoma. Br J Obstet Gynaecol 1987 94: 991 4.
3. Morrow CP Bundy BN Korman RJ et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991 40: 55 65.
4. Gal D Recio FO Zamorovic D Tancer ML. Lymphvascular space involvement - a prognostic indicator in endometrial carcinoma. Gynecol Oncol 1991 42: 142 5.
5. Inoue Y Obata K Abe K et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer 1996 78: 1447 51.
6. Yura Y Tauchi K Koshiyama M et al. Parametrial involvement in endometrial carcinomas: its incidence and correlation with other histological parameters. Gynecol Oncol 1996 63: 114 9.
7. Aoki Y Kase H Watanabe M Sato T Kurata H Tanaka K. Stage III endometrial cancer: analysis of prognostic factors and failure patterns after adjuvant therapy. Gynecol Oncol 2001 83: 1 5.
8. Mariani A Webb MJ Keeney GL Aletti G Podratz KC. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol 2002 86: 38 44.
9. Mariani A Webb MJ Keeney GL Haddoek MG Aletti G Podratz KC. Stage IIIC endometrioid corpus cancer includes distinct subgroups. Gynecol Oncol 2002 87: 112 7.
10. Mariani A Webb MJ Keeney GL Aletti G Podratz KC. Endometrial cancer: predictors of peritoneal failure. Gynecol Oncol 2003 89: 236 42.
11. Mariani A Keeney GL Aletti G Webb MJ Haddock MG Podratz KC. Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol 2004 92: 833 8.
12. Watari H Todo Y Takeda M Ebina Y Yamamoto R Sakuragi N. Lymphvascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol Oncol 2005 96: 651 657.
13. Briet JM Hollema H Reesink N et al. Lymph vascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol 2005 96: 799 804.
14. Cohn DE Horowitz NS Mutch DG Kim S-M Manolitsas T Fowler JM. Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?. Gynecol Oncol 2002 87: 243 6.
15. Zaino RJ. Lymph-vascular space invasion in endometrial adenocarcinoma: confusion, confessions and conclusions. Gynecol Oncol 2002 87: 240 2.
16. Sidawy MK Silverberg SG. Endometrial carcinoma. Pathologic factors of therapeutic and prognostic significance. Pathol Annu 1992 27: 153 85.
17. Zaino RJ Kurman RJ Diana KL Morrow CP. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. Cancer 1994 75: 81 6.
18. Hachisuga T Kaku T Fukuda K et al. The grading of lymphvascular space invasion in endometrial carcinoma. Cancer 1999 86: 2090 7.
19. Tsuruchi N Kaku T Kamura T et al. The prognostic significance of lymphvascular space invasion in endometrial cancer when conventional hematoxylin and eosin staining is compared to immunohistochemical staining. Gynecol Oncol 1995 57: 307 12.
20. Alexander-Sefre F Singh N Ayhan A Thomas JM Jacobs IJ. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer. Gynecol Oncol 2004 92: 653 9.
21. Marone A Scambia G Ferrandina G et al. Nm 23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion. Br J Cancer 1996 74: 1063 8.
22. Stefansson IM Salvesen HB Akslen LA. Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer. J Clin Oncol 2004 22: 1242 52.
23. Cirisano FD Robboy SJ Dodge RK et al. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Gynecol Oncol 1999 74: 385 94.
24. Sakuragi N Hareyama H Todo Y et al. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma. Acta Obstet Gynecol Scand 2000 79: 311 6.
25. Scholten AN Creutzberg CL Noorduik EM Smitvth BM. Long-term outcome in endometrial carcinoma favors a two instead of three-tiered grading system. Int J Radiat Oncol Biol Phys 2002 52: 1067 74.
26. Smid-Koopman E Blok LJ Helmerhorst TJM et al. Gene expression profiling in human endometrial cancer tissue samples: utility and diagnostic value. Gynecol Oncol 2004 93: 292 300.
27. Lindauer J Fowler JM Manolitsas TP et al. Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer. Gynecol Oncol 2003 91: 547 51.
28. Plentl AA Friedman EA. Lymphatic system of the female genitalia, Vol. 2. Major Problems in Obstetrics and Gynecology. Philadelphia, PA: WB Saunders Company, 1971: 117.
29. Longacre TA Hendrickson MR. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion. Am J Surg Pathol 1999 23: 69 78.
30. Mittal KR Barwick KW. Diffusely infiltrating adenocarcinoma of the endometrium: a subtype with poor prognosis. Am J Pathol 1988 12: 754 8.
31. Lee KR Vacek PM Belinson JL. Traditional and non-traditional histopathological predictors of recurrence in uterine endometrioid adenocarcinoma. Gynecol Oncol 1994 54: 10 8.
32. Eltabbakh GH Moore AD. Survival of women with surgical stage II endometrial cancer. Gynecol Oncol 1999 74: 80 5.
33. Fanning J Alvarez PM Tsukada Y Piver MS. Cervical implantation metastases by endometrial adenocarcinoma. Cancer 1991 68: 1335 9.
34. Jacques SE, Lawrence WD. Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinico-pathologic study of 23 cases. Gynecol Oncol 1990 37: 401 7.
35. Mittal KR Barwick KW. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades and excellent prognosis. Gynecol Oncol 1993 49: 197 201.
36. Alexander-Sefre F Singh N Ayhan A Salveson HB Willbanks G Jacobs IJ. Detection of tumor lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry. J Clin Pathol 2003 56: 786 8.